Stock Taper 
LMAT
$81.86
▼ DOWN 0.56% (-0.46)
KEY STATISTICS
Market Cap$1.87 B
52w High$118.01
52w Low$78.65
Dividend Yield1.20%
FrequencyQuarterly
P/E30.10
Volume419.89K
Shares Out.22.85M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
George W. LeMaitre
COMPENSATION 2026
Salary$806,347
Stock Awards$1,050,000
Incentive Plan Pay$680,015
All Other Comp.$194,628
Total$3,780,990
ABOUT
SECTOR
Healthcare
WENT PUBLIC
October 19, 2006
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
651
PRICE TARGET
Target High$135.00
Target Low$95.00
Target Median$115.00
Target Consensus$115.00
UPCOMING EARNINGS
DateNov 5, 2026
DayThursday
Rev. Est.$67.39M
NOV
5
THU
PRICE
$81.86 ▼ DOWN 0.56% (−$0.46)About LeMaitre Vascular, Inc.
https://www.lemaitre.com ↗LeMaitre Vascular designs and markets medical devices and implants worldwide for treating peripheral vascular disease, including catheters, shunts, grafts, patches, and closure systems.
INDUSTRY
Medical - Instruments & Supplies
A PRODUCT LEMAITRE VASCULAR, INC. IS KNOWN FOR
Artegraft® Collagen Vascular Graft
Artegraft, a biologic vascular graft from processed bovine carotid artery, is used in blood flow procedures like bypasses and hemodialysis shunts, forming a key and expanding product line for LeMaitre Vascular.
Revenue by Products
| Icon | PRODUCT | Q2-2012 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|---|
 | Operating Segments | — | $59.87M | $64.23M ▲ | $61.05M ▼ |
 | Open Vascular | $11.85M | — | — | — |
 | Endovascular and Other | $2.51M | — | — | — |
Revenue by Geography
| Map | REGION | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|---|
 | Americas | $73.54M | — | — | — |
 | UNITED STATES | — | $34.63M | $36.66M ▲ | $34.59M ▼ |
 | EMEA | $30.57M | — | — | — |
 | Other Countries | — | $14.4M | $15.87M ▲ | $14.81M ▼ |
 | Asia Pacific | $7.46M | — | — | — |
 | GERMANY | — | $3.98M | $4.46M ▲ | $4.48M ▲ |
 | CANADA | — | $3.72M | $3.96M ▲ | $3.83M ▼ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
189
LISTED HERE
26
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
77.08%
HOLDERS
465
TOP 12 OF 465 · RANKED BY POSITION SIZE
Blackrock Inc.
Blackrock, Inc.
Vanguard Group Inc
Conestoga Capital Advisors, LLC
Marxe Austin W & Greenhouse David M
First Trust Advisors LP
Congress Asset Management Co /Ma
Copeland Capital Management, LLC
Geneva Capital Management LLC
State Street Corp
Geode Capital Management, LLC
Price T Rowe Associates Inc /Md/
RATINGS SNAPSHOT
Overall rating: B+
Discounted Cash Flow4
Return On Equity4
Return On Assets5
Debt To Equity2
Price To Earnings1
Price To Book2
Overall Score3
INSIDER TRADES
★
OFFICER: CHIEF FINANCIAL OFFICER
LeBlanc Dorian Paul
Purchase · 3 shares
2026-06-04
★
DIRECTOR, OFFICER: PRESIDENT AND DIRECTOR
Roberts David B
Purchase · 1 shares
2026-06-04
★
OFFICER: SENIOR V. P., OPERATIONS
Kamke Trent G
Purchase · 3 shares
2026-06-04
★
DIRECTOR, OFFICER: CHAIRMAN AND CEO
LeMaitre George W
Sale · 12.0K shares
2026-06-04
MOST RECENT ANALYST GRADES
GRADE SUMMARY
EQUAL WEIGHT 1
OUTPERFORM 1
MARKET OUTPERFORM 1
BUY 1
4 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 TWST | $145.59 | COMPARE |
 HAE | $108.80 | COMPARE |
 AVAH | $13.16 | COMPARE |
 ACHC | $27.82 | COMPARE |
 ATRC | $48.98 | COMPARE |
 INSP | $62.36 | COMPARE |
 PAHC | $36.32 | COMPARE |
 PRCT | $21.68 | COMPARE |